Lensar (LNSR) Liabilities and Shareholders Equity (2019 - 2026)

Lensar's (LNSR) quarterly Liabilities and Shareholders Equity came in at $66.2 million in Q1 2026, down 9.23% year-on-year from $73.0 million in Q1 2025, and down 7.29% on a QoQ basis from $71.4 million in Q4 2025.

Lensar (LNSR) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

Lensar (LNSR) has 8 years of Liabilities and Shareholders Equity data on file, last reported at $66.2 million in Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 9.23% year-over-year to $66.2 million in Q1 2026; TTM through Mar 2026 was $278.3 million, a 5.93% increase from a year earlier, with the FY2025 full-year figure at $71.4 million, up 7.74% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $66.2 million, down from $71.4 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for LNSR reached as high as $73.0 million in Q1 2025 and fell as low as $52.0 million in Q1 2023.
  • Historically, Liabilities and Shareholders Equity has averaged $64.7 million across 5 years, with a median of $66.2 million in 2026.
  • Across the five-year window, Liabilities and Shareholders Equity retreated 19.53% in 2022 and grew 29.29% in 2023, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $55.8 million in 2022, then grew by 24.61% to $69.6 million in 2023, then dropped by 4.73% to $66.3 million in 2024, then increased by 7.74% to $71.4 million in 2025, then slipped by 7.29% to $66.2 million in 2026.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $66.2 million in Q1 2026, $71.4 million in Q4 2025, and $70.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 Lensar 70.05 Mn 72.73 Mn 6.38 Mn 66.22 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 66.22 Mn
Dec 31, 2025 71.43 Mn
Sep 30, 2025 70.20 Mn
Jun 30, 2025 70.41 Mn
Mar 31, 2025 72.96 Mn
Dec 31, 2024 66.30 Mn
Sep 30, 2024 62.02 Mn
Jun 30, 2024 61.41 Mn
Mar 31, 2024 66.13 Mn
Dec 31, 2023 69.59 Mn
Sep 30, 2023 70.85 Mn
Jun 30, 2023 71.20 Mn
Mar 31, 2023 51.96 Mn
Dec 31, 2022 55.84 Mn
Sep 30, 2022 54.80 Mn
Jun 30, 2022 58.70 Mn
Mar 31, 2022 60.30 Mn
Dec 31, 2021 66.47 Mn
Sep 30, 2021 68.10 Mn
Jun 30, 2021 72.48 Mn